万利国际
Latest News
2026-04-22
Hengrui Pharma Reports Q1 2026 Results with Revenue and Net Profit Growth
More News
All
Oncology
Autoimmune
Other Areas
Target
Androgen Receptor
ATR
Aβ
BTK
CDK4/6
Claudin 18.2
CTGF
EGFR/HER2
EZH2
GLP-1/GIP
GnRH
HER2
IL-17A
PARP
PD-1
PD-L1
PD-L1/TGF-β
Year
2026
2025
2024
2023
2022
2021
1900